retatrutide cardiovascular benefits Retatrutide, Tirzepatide and Survodutide in Heart Research Doctor Explains The Side Effects

The SOUL trial is being described as a landmark study for cardiovascular outcomes in high-risk diabetes patients

Crucially, this study identified profound sex-specific differences in how this oxidative stress manifests

Mehra, S., Sahay, S

In clinical practice, based on clinical response or intolerance, the starting dose of medication is 10 mg/week, with increases of 5 mg every 24 weeks, up to a maximum dose of 2030 mg/week (Visser and van der Heijde 2009

In the middle third of the anterior thigh, this layer typically ranges from 5mm to 15mm in most adults

This can make it difficult to determine if the medication or the resulting weight loss is the primary trigger